Toronto, April 16: The first clinical trial of the Covid-19 vaccine made in Canada has been conducted. Developed by University of Alberta researcher and CEO of Entos Pharmaceuticals, Dr. John Lewis, the phase 1 of the clinical trial of that vaccine has been applied to the human body yesterday. →
Canadian National Multilingual Newsgroup
Welcome to the Canadian National Multilingual News Group (CNMNG). This is a project made possible through funding by Canadian Heritage. CNMNG aims to gather news researched and written by a corps of Canadian-based journalists/writers from the country’s multilingual community groups. The overall goal is to inform, analyze and critique the issues of the day in a professional manner and to provide that to publishers and editors active in the ethnocultural-multilingual press and media whose experience provides them with a perspective that is sensitive to news relevant to their own language group.
